A Real World Study on Fabulous® Thoracic Aortic Stent System for Stanford B Aortic Dissection

NCT05965271 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2023-08-03

No results posted yet for this study

Summary

A multicenter, retrospective study to evaluate the real-world efficacy of the Fabulous thoracic aortic stent system in the treatment of Stanford Type B aortic dissection.

Conditions

  • Aortic Dissection

Interventions

DEVICE

Fabulous Thoracic Aortic Stent System

Endovascular treament in patients with aortic dissection with Fabulous Thoracic Aortic Stent System

Sponsors & Collaborators

  • Hangzhou Endonom Medtech Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05965271 on ClinicalTrials.gov